Kevin Foust
Affiliations: | Neuroscience | Ohio State University, Columbus, Columbus, OH |
Google:
"Kevin Foust"Mean distance: 18.48 (cluster 19)
Parents
Sign in to add mentor| Brian K. Kaspar | grad student | Nationwide Children's Hospital | |
| Ron Mandel | grad student |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Powers S, Likhite S, Gadalla KK, et al. (2023) Novel MeCP2 Gene Therapy is Effective in a Multicenter Study using Two Mouse Models of Rett Syndrome and is Safe in Non-human Primates. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Foust KD, Wang X, McGovern VL, et al. (2022) Retraction Note: Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nature Biotechnology |
| Thomsen G, Burghes AHM, Hsieh C, et al. (2021) Biodistribution of onasemnogene abeparvovec DNA, mRNA and SMN protein in human tissue. Nature Medicine |
| Mendell JR, Al-Zaidy S, Shell R, et al. (2017) Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. The New England Journal of Medicine. 377: 1713-1722 |
| Gombash SE, Cowley CJ, Fitzgerald JA, et al. (2017) Systemic gene delivery transduces the enteric nervous system of guinea pigs and cynomolgus macaques. Gene Therapy |
| Shell R, Al-Zaidy S, Arnold WD, et al. (2017) AVXS-101 Phase 1 gene therapy clinical trial in SMA Type 1: Interim data demonstrates improvements in supportive care use European Journal of Paediatric Neurology. 21: e14 |
| Mendell JR, Al-Zaidy S, Shell R, et al. (2017) AVXS-101 Phase 1 gene therapy clinical trial in SMA Type 1: Event free survival and achievement of developmental milestones European Journal of Paediatric Neurology. 21: e13-e14 |
| Bosch ME, Aldrich A, Fallet R, et al. (2016) Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3). The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 36: 9669-82 |
| Song S, Miranda CJ, Braun L, et al. (2016) Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nature Medicine |
| Gombash SE, Foust KD. (2016) Systemic Gene Therapy for Targeting the CNS. Methods in Molecular Biology (Clifton, N.J.). 1382: 231-7 |